(Q41902053)

English

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer

scientific article published on 20 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Li Pang

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Jing Wang

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Yanwen Jiang

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Liangan Chen

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

publication date

20 June 2013

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Experimental and Therapeutic Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

6

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

355-360

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Estimates of cancer incidence and mortality in Europe in 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Cancer cells in transit: the vascular interactions of tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, an

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Increased serum CA-125 levels in patients with lung cancer post thoracotomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Serum levels of nicotinamide N-methyltransferase in patients with lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decline of serum CYFRA21-1 during chemoradiotherapy of NSCLC: a probable predictive factor for tumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers in the lung cancer diagnosis: a clinical perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/ETM.2013.1171

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41902053&oldid=1929572074"